Kathryn Pennington, MD
Gynecologic Oncology · Seattle, WANPI 1336265511
Payments from drug & device makers
What this record shows
7 manufacturers reported payments, led by Intuitive Surgical at 45.5% of the total.
Across 20 payments — averaging $83.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$757
- AstraZeneca$421
- AbbVie$251
- Seagen Inc.$99
- GSK$88
- Pfizer$29
- plus $19 from 1 others
Across 497 payments — averaging $1206.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- GSK$305K
- Springworks Therapeutics, Inc.$139K
- AstraZeneca$121K
- Genmab U.S., Inc.$34K
- Merck$795
What the payments were for
- Food & beverage$81449%
- Education$84951%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 2 | $757 |
| AstraZeneca | 8 | $421 |
| AbbVie | 6 | $251 |
| Seagen Inc. | 1 | $99 |
| GSK | 1 | $88 |
| Pfizer | 1 | $29 |
| Daiichi Sankyo Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$750
- LYNPARZA$238
How this compares
$1,663 in reported general payments places this provider in the 60th percentile of 36 gynecologic oncology providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 15 | $97 |
| Oxycodone Hcl | 15 | $65 |
| Ibuprofen | 13 | $52 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Seattle
- Chirag ShahSeattle$732K
- Fernanda MusaSeattle$120K
- Bobbie RimelSeattle$41K
- Nicole FlemingSeattle$20K
- Renata UrbanSeattle$7K
- Amy BrockmeyerSeattle$4K
- Amy BondurantSeattle$2K
- Soledad JorgeSeattle$1K
- Elise SimonsSeattle$459
- Allison BarrieSeattle$428
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.